Concepedia

Deborah Stocken

DS

Statistics

Publications

82

Citations

16.1K

H-Index

45

Active since

2001

Affiliations

Newcastle University(Current)

University of Leeds

University of Birmingham

Newcastle upon Tyne Hospitals NHS Foundation Trust

Cancer Research UK Clinical Trials Unit

Deborah Stocken is an author at Newcastle University specializing in medicine, oncology, and chemotherapy.

ORCID

Publications per year

2001–2025

82

Publications

82

A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer

John P. Neoptolemos, Deborah Stocken, Helmut Friess et al. · New England Journal of Medicine · 2004 · 2.7K citations

, , +16

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

Matthew J. Armstrong, Piers Gaunt, Guruprasad P. Aithal et al. · The Lancet · 2015 · 2.1K citations · Full text

, , +5

Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection

John P. Neoptolemos, Deborah Stocken, Claudio Bassi et al. · JAMA · 2010 · 1.4K citations

, , +17

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

Richard Fox, Daniel H. Palmer, Hassan Malik et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

, , +9

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

David Cunningham, Ian Chau, Deborah Stocken et al. · Journal of Clinical Oncology · 2009 · 818 citations · Full text

, , +12

1–5 of 82